Pharma & Biotech Patent Litigation in Europe

Day 1 - Tuesday, May 23, 2023

8:30	Co-Chairs’ Opening Remarks: Pharma & Biotech Patent Litigation Year in Review
9:00	Status Report on Unitary Patent Applications: Examining Filing Trends Three Months Into The Sunrise Period
9:30	Developing Winning Patent Litigation Strategies for the Unified Patent Court and for Concurrently Protecting Your Patents in Jurisdictions Outside of the UPC
11:00	Morning Coffee Break
11:30	UPC Judges’ Roundtable: Important Considerations for Practitioners Entering Into the Unified Patent Court
12:30	Networking Luncheon
1:30	International Regulatory Think Tank: Anticipating the Impact of EU Regulatory Change on Pharma and Biotech Companies
2:30	The Future of Plausibility: Anticipating the Implications of the EPO’s Decision in BOA Referral G 2/21
3:30	Afternoon Break
3:45	Examining the Impact of Recent SPC Referral Cases and Addressing Key Questions on the Future of Unitary SPCs
4:00	Assessing the Uptake of the SPC Manufacturing Waiver and Recent Disputes Arising from Manufacturing Waiver Regulations
4:30	Conference Adjourns

Day 2 - Wednesday, May 24, 2023

8:30	Co-Chairs’ Welcome Back and Recap of Day 1
9:00	Transnational Tactics for Avoiding and Defending Contributory and Induced Infringement Claims
10:00	Global Strategies for Biosimilars and Biologics Patent Litigation
11:00	Morning Coffee Break
11:30	Alternative Dispute Resolution: The Shift from Ordinary Proceedings Towards ADR
12:30	Networking Luncheon for Speakers and Delegates
1:30	Tracking Changes in Competition Law: Enforcement, Litigation, Settlements and Economic Considerations
2:15	Successfully Claiming Antibody Patents in Europe and the U.S.: Incorporating Takeaways from the Latest Case Law Into Your Prosecution Strategy
3:15	Afternoon Break
3:30	Examining the Impact of Legal and Regulatory Developments in the U.S. and China
4:30	Navigating the Patenting Challenges Of AI-Assisted Drug Discovery and Development
5:30	Conference Concludes